CN205612515U - Be used for hemostatic device in uterus - Google Patents
Be used for hemostatic device in uterus Download PDFInfo
- Publication number
- CN205612515U CN205612515U CN201620317554.9U CN201620317554U CN205612515U CN 205612515 U CN205612515 U CN 205612515U CN 201620317554 U CN201620317554 U CN 201620317554U CN 205612515 U CN205612515 U CN 205612515U
- Authority
- CN
- China
- Prior art keywords
- sacculus
- uterus
- catheterization body
- hemostasis
- model
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Surgical Instruments (AREA)
Abstract
The utility model provides a be used for hemostatic device in uterus, it has the catheterization body, and catheterization body one side is equipped with the intake pipe, and the intake pipe other end has the venthole, and catheterization body front end system has the thickening sacculus, and at the hob of the external side of catheter cover case ring shape sprue, near the fixed dog of intake pipe department's installation, it has the swivel nut of taking the handle to overlap on the fixed dog, screw in the swivel nut is corresponding with the screw on the hob, and catheterization body front end is equipped with first through -hole and second through -hole. The utility model discloses in mainly being used in the case that the early pregnancy stream of people of uterus scar department bled, can solve the fixed difficult problem of current catheter lower extreme, can adjust fixedly simultaneously according to patient's cervical length, make the sacculus of palace intracavity hug closely palace chamber wall, reduce the uterus dead space to according to how many adjusted spiral poles of amount of bleeding or drawing liquid decompression, the oppression hemostatic effect showing, and it is normally movable not influence patient.
Description
Technical field
This utility model relates to medical equipment, is a kind of device for uterine hemostasis.
Background technology
In medicinal, at Uterine Scar, early pregnancy abortion is gynecological's operation most common, most widely used,
Uterine cavity is hemorrhage is also frequently problem in this kind of operation, uses cavity of uterus to place double lumen catheter as drain
Pipe, balloon compression hemostasis is the method commonly used clinically.According to uterine cavity size and Compressive Hemostasis by sacculus water filling
20~40ml hemostasiss by compression, another termination drainage bag of sacculus observes blood volume.The published patent No.
201320019215, the structure of title uterine hemostasis sacculus is: in being placed in liquid sacculus in double channel catheter one end,
Inject saline in sacculus is inserted cavity of uterus, make sacculus expansion be affixed on uterus inwall and play hemostasis by compression effect;But
Clinical practice process there is the problem that the fixing difficulty in double channel catheter outer end, and sacculus is expanded after placing in uterine cavity fluid injection again,
An outside pulling force tractive catheter is needed to keep some tension.In clinic through frequently with wide adhesive plaster by leading after drop-down
Pipe end is fixed on inside patient thigh or binding normal saline bottle produces pulling force, makes sacculus only be close to uterus compressing
Blood, there is the problem that and easily affected by patient activity or position, does not reaches the certain pulling force of holding and makes sacculus fixed
Position realizes the effect of uterus hemostasis by compression in bleeding part, and the position both having limited patient is movable, affects again hemostasis by compression
Effect.
Utility model content
The purpose of this utility model provides a kind of device for uterine hemostasis, is used primarily at Uterine Scar the most pregnant
In the case that the artificial abortion that is pregnent is hemorrhage, it is possible to solve the fixing difficult problem in existing catheter lower end, simultaneously can be according to patient palace
Neck length degree is adjusted fixing, and makes intrauterine sacculus be close to uterine cavity wall, reduces uterus dead space, and according to amount of bleeding
How many adjustment screw rods or drawing liquid decompression, Compressive Hemostasis is notable, does not affect patient's normal activity.
The purpose of this utility model is achieved through the following technical solutions: of the present utility model for uterine hemostasis
Device, it has urethral catheterization body, urethral catheterization body side to be provided with air inlet pipe, and the air inlet pipe other end has venthole, catheter
Body front end is shaped with thickening sacculus, at the screw rod of catheter external side suit band annular sprue, at air inlet pipe
Fixed stop is installed, fixed stop is cased with the swivel nut of band handle, the screw thread in described swivel nut and the spiral shell on screw rod
Stricture of vagina is corresponding, and urethral catheterization body front end is provided with the first through hole and the second through hole.Fixed stop is ring-type fluted shape.Circle
Annular sprue is that duroplasts is made.Annular sprue is connected for fixing with screw rod.Thicken a diameter of 3-6 of sacculus
Centimetre.
This utility model has the beneficial effects that: transformed by catheter sacculus to uterine hemostasis in clinic, solves
The fixing difficult problem in catheter lower end, can be adjusted sacculus according to patient cervical length by screw rod simultaneously and consolidate
Location is put, and in making uterine cavity, sacculus is close to uterine cavity wall, reduces uterus dead space, and Compressive Hemostasis is notable, does not affect disease
People's normal activity.And adjust screw rod pulling force or drawing liquid decompression according to amount of bleeding, when 24~48 is little, vagina is without hemorrhage
This utility model hemostasis device can be extracted, be truly realized the using effect that can be suitable for all ages and classes patient, can be wide
General popularization and application.
Typical case falls ill: the case that at Uterine Scar, early pregnancy artificial abortion is hemorrhage, by using this utility model in utero ball
Capsule hemostasis device hemostasis by compression achieves preferable curative effect, and model case is as follows:
Example 1, patient 36 years old, pregnant 2 produce 1, cesarean postoperate 2 years.Menolipsis 48 days, vagina is over the most hemorrhage 3 days
Examine.B ultrasonic: in cavity of uterus, nearly hypomere antetheca is visited and the low echo area of 1.2cm × 1.0cm, inside sees yolk sac.Blood β
-HCG 11630.00U/L.Patient requests's termination of pregnancy, gives artificial abortion in outpatient service, and operation smoothly, is shown in fine hair
And decidua tissue, but postoperative hemorrhage is many, gives intramuscular injection Leonurus Heterophyllus injection and slightly reduces and go home.Patient the 2nd day is hemorrhage
The most more check, B ultrasonic: see uterine cavity antetheca irregular agglomerate echo, be diagnosed as gestation at the cicatrix of uterus, take in institute
I.e. give cavity of uterus and place this utility model in utero sacculus hemostasis device, in sacculus water filling 40ml hemostasis by compression, multiple
Look into liver function normal, give methotrexate 20mg intramuscular injection qd, totally 5 times, mifepristone 50mg, every 12h 1 time, even
Taking 5d, after this utility model in utero sacculus hemostasis device indwelling 2d, vagina is fully recovered after hemorrhage, extracts this practicality new
Type hemostasis device.
Example 2, patient 30 years old, pregnant 3 produce 1, cesarean postoperate 9 years.Because of menolipsis 48 days, in little outpatient service from taking miscarriage
Within after medicine 3 days, having no that tissue substance is discharged but hemorrhage examined more, transvaginal ultrasound shows: have no pregnant capsule, uterus in uterine cavity
Antetheca hypomere has the low echo enclosed mass of about 3 0cm × 3 2cm, blood HCG 7865U/L.It is diagnosed as uterus
Gestation at cicatrix, outpatient service is hemorrhage more, at once with oval when giving row uterine curettage with " imperfection drug induced abortion "
Ward is taken in after pincers clamp cervix uteri.First employing Metotrexate Combined with Mifepristone Drug therapy: MTX20mg intramuscular injection qd,
Totally 5 times, and oral mifepristone 50mg, every 12h 1 time, it serve on 5d, give antibacterials prevention simultaneously and infect.
Monitoring β-HCG gives the clearing heat in the pericardium, all to bleed profusely in art after dropping to 1000U/L, and the clearing heat in the pericardium is complete the most immediately at uterine cavity
Interior placement this utility model in utero sacculus hemostasis device, according to uterine cavity size and Compressive Hemostasis in sacculus water filling
20~40ml hemostasiss by compression, observe without obvious hemorrhage rear fixing screw rod, this utility model in utero sacculus hemostasis device
End connects drainage bag and observes blood volume.And adjust screw rod according to haemostatic effect 4~10h.And often 12h is the most every
Haemostatic effect is observed in secondary drawing liquid 10ml decompression, and 24~48h vaginas are fully recovered after hemorrhage, extracts this utility model hemostasis
Device.
Example 3, patient 26 years old, pregnant 2 produce 1, cesarean postoperate 3.Because of menolipsis 42 days, vagina was over dripping hemorrhage 3 days
Examine.Gynecologial examination: intravaginal courageous and upright secretions on a small quantity, cervix uteri is smooth, normal in size, anteversion of uterus, and pregnant 40 days big
Little, lower uterine segment expands, and matter is soft, and without tenderness, double accessory is normal.Vagina supersonic inspection shows palace body 4.3cm × 4.0cm
× 3.8cm, cervix uteri nearly internal orifice uterus visible 1.2cmx1.4cm heterogeneous echopattern agglomerate to the front, make a definite diagnosis uterine incision
At cicatrix, early pregnancy admits to hospital.First employing Metotrexate Combined with Mifepristone Drug therapy: MTX20mg intramuscular injection qd,
Totally 5 times, and oral mifepristone 50mg, every 12h 1 time, it serve on 5d, give antibacterials prevention simultaneously and infect.
Monitoring β-HCG gives the clearing heat in the pericardium, all to bleed profusely in art after dropping to 1000U/L, and the clearing heat in the pericardium is complete the most immediately at uterine cavity
Interior placement this utility model in utero sacculus hemostasis device, according to uterine cavity size and Compressive Hemostasis in sacculus water filling
20~40ml hemostasiss by compression, observe without obvious hemorrhage rear fixing screw rod, this utility model in utero sacculus hemostasis device
End connects drainage bag and observes blood volume.And adjust screw rod according to haemostatic effect 4~10h.And often 12h is the most every
Haemostatic effect is observed in secondary drawing liquid 10ml decompression, and 24~48h vaginas are fully recovered after hemorrhage, extracts this utility model hemostasis
Device.
Example 4, patient, female, 23, pregnant 1 produces 1, cesarean postoperate 1 year half, and because of menolipsis 45 days, vagina bled 1 on a small quantity
It is gone to a doctor.Uterus normal in size is shown in ultrasound diagnosis, 0.9cmx1 2cm seen from lower uterine segment antetheca incisional scar ×
1.3cm heterogeneous echopattern district.Make a definite diagnosis uterine incision cicatrix position gestation to admit to hospital.First use methotrexate associating rice
Mifepristone Drug therapy: MTX20mg intramuscular injection qd, totally 5 times, and oral mifepristone 50mg, every 12h 1 time, even
Take 5d, give antibacterials prevention simultaneously and infect.Monitoring β-HCG gives the clearing heat in the pericardium, art after dropping to 1000U/L
In all bleed profusely, the clearing heat in the pericardium is complete places this utility model in utero sacculus hemostasis device, and root the most immediately in uterine cavity
According to uterine cavity size and Compressive Hemostasis in sacculus water filling 20~40ml hemostasis by compression, observe without obvious hemorrhage after solid
Determining screw rod, this utility model in utero sacculus hemostasis device end connects drainage bag and observes blood volume.And according to hemostasis effect
Really 4~10h adjust screw rod.And every 12h gradually every time drawing liquid 10ml decompression observe haemostatic effect, 24~48h
Vagina is fully recovered after hemorrhage, extracts this utility model hemostasis device.
The patient of above model case all apply in utero sacculus local pressing type hemostasia and control hemorrhage, saved uterus from damage
And make patient from the hardship operated on.Postoperative without infecting, without palace wall and cervix uteri pressurized ischemic necrosis, menstruation recovery, by
This proves that sacculus indwelling time and pressure, in safety range, do not cause complication, can in basic unit clinical, special or
The popularization and application of condition name without Emergent intervention.
Accompanying drawing explanation
Fig. 1 is structural representation of the present utility model.Fig. 2 is the structural representation of screw rod 5 in Fig. 1.Fig. 3
Right TV structure schematic diagram for Fig. 2.
Detailed description of the invention
Device for uterine hemostasis of the present utility model, it have urethral catheterization body 1, urethral catheterization body 1 side be provided with into
Trachea 12, air inlet pipe 12 other end has venthole 10, urethral catheterization body 1 front end to be shaped with thickening sacculus 7, in urethral catheterization
It is set with the screw rod 5 of band annular sprue 6 outside body 1, fixed stop 2 is installed at air inlet pipe 12, Gu
Determine to be cased with on block 2 swivel nut 4 of band handle 3, the screw thread 11 in described swivel nut 4 and the screw thread phase on screw rod 5
Correspondence, urethral catheterization body 1 front end is provided with the first through hole 8 and the second through hole 9.Described fixed stop 2 is ring-type slot type
Shape, annular sprue 6 is made for duroplasts.Make swivel nut 4 can in slot type fixed stop 2 rotary moveable.Institute
State annular sprue 6 to be connected for fixing with screw rod 5.This structural strengthening annular sprue 6 and screw rod 5
Stability.A diameter of 3-6 centimetre of described thickening sacculus 7, it is capable of the high pressure of sacculus 7, Gao Rongji
The purpose of high-tension.
When this utility model is installed, fixed stop 2 is fixed on urethral catheterization body 1 upper surface, and annular hand grip 3 is stuck in solid
Determining in the cannelure of block 2, the screw thread 11 in swivel nut 4 is meshed with the screw thread on screw rod 5, passes through air inlet
Pipe 12 makes gas enter in sacculus 7.During use, gas is made to enter sacculus 7, and on request by air inlet pipe 12
Inject quantitative liquid, make to be close to the sacculus 7 of expansion of liquids on hemorrhage uterine cavity wall, then turning handle 3
Promote screw rod 5 to move ahead, make the annular sprue 6 on screw rod 5 be adjacent to vaginal orifice outer wall, play fixing ball
The effect of capsule 7 realizes hemostasis purpose.Described urethral catheterization body 1 front end be provided with the first through hole 8 and the second through hole 9 for
Drawing palace intracavity blood, described urethral catheterization body 1 is known technology.The non-detailed description of this utility model is known technology.
Claims (5)
1., for the device of uterine hemostasis, it has urethral catheterization body (1), urethral catheterization body (1) side to be provided with air inlet pipe
(12), air inlet pipe (12) other end has venthole (10), it is characterised in that: urethral catheterization body (1) front end system
There is thickening sacculus (7), at the screw rod (5) of urethral catheterization body (1) outside suit band annular sprue (6), lean on
Fixed stop (2) is installed at nearly air inlet pipe (12) place, and fixed stop (2) is cased with the swivel nut (4) of band handle (3),
Screw thread (11) in described swivel nut (4) is corresponding with the screw thread on screw rod (5), and urethral catheterization body (1) is front
End is provided with the first through hole (8) and the second through hole (9).
Device for uterine hemostasis the most according to claim 1, it is characterised in that: fixed stop (2)
For ring-type fluted shape.
Device for uterine hemostasis the most according to claim 1, it is characterised in that: annular sprue (6)
Make for duroplasts.
Device for uterine hemostasis the most according to claim 1, it is characterised in that: annular sprue (6)
It is connected for fixing with screw rod (5).
Device for uterine hemostasis the most according to claim 1, it is characterised in that: thicken sacculus (7)
A diameter of 3-6 centimetre.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201620317554.9U CN205612515U (en) | 2016-04-14 | 2016-04-14 | Be used for hemostatic device in uterus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201620317554.9U CN205612515U (en) | 2016-04-14 | 2016-04-14 | Be used for hemostatic device in uterus |
Publications (1)
Publication Number | Publication Date |
---|---|
CN205612515U true CN205612515U (en) | 2016-10-05 |
Family
ID=57030541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201620317554.9U Expired - Fee Related CN205612515U (en) | 2016-04-14 | 2016-04-14 | Be used for hemostatic device in uterus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN205612515U (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105708514A (en) * | 2016-04-14 | 2016-06-29 | 吴德印 | Device for uterus hemostasis |
WO2019105519A1 (en) * | 2017-12-03 | 2019-06-06 | Abd Elaal Nasser Kamal | Tranexamic acid coated or eluted uterine balloon and co-attached cervical shutter in the management of postpartum haemorrhage |
CN110680442A (en) * | 2019-10-16 | 2020-01-14 | 张玲 | A sacculus system for postpartum recovery |
CN111388047A (en) * | 2020-03-27 | 2020-07-10 | 杭州市第一人民医院 | Uterine cavity hemostasis assembly for postpartum puerpera |
-
2016
- 2016-04-14 CN CN201620317554.9U patent/CN205612515U/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105708514A (en) * | 2016-04-14 | 2016-06-29 | 吴德印 | Device for uterus hemostasis |
WO2019105519A1 (en) * | 2017-12-03 | 2019-06-06 | Abd Elaal Nasser Kamal | Tranexamic acid coated or eluted uterine balloon and co-attached cervical shutter in the management of postpartum haemorrhage |
US11717325B2 (en) | 2017-12-03 | 2023-08-08 | Nasser Kamal Abd Elaal | Medicated uterine balloon with cervical barricade for management of postpartum hemorrhage |
CN110680442A (en) * | 2019-10-16 | 2020-01-14 | 张玲 | A sacculus system for postpartum recovery |
CN110680442B (en) * | 2019-10-16 | 2020-10-27 | 张玲 | A sacculus system for postpartum recovery |
CN111388047A (en) * | 2020-03-27 | 2020-07-10 | 杭州市第一人民医院 | Uterine cavity hemostasis assembly for postpartum puerpera |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105708514A (en) | Device for uterus hemostasis | |
CN205612515U (en) | Be used for hemostatic device in uterus | |
CN202776442U (en) | Packing device for treating uterine bleeding | |
CN107670166A (en) | Three chamber uterine neck balloon dilatation catheters | |
CN202637025U (en) | Sacculus uterine support | |
CN205494630U (en) | Prevent sacculus uterus support of oppression | |
CN109513097A (en) | A kind of two-tube balloon-stent for preventing and treating Asherman's syndrom | |
CN203290958U (en) | Three-cavity water sac used for hemostasis by compression in early pregnant uterus cavity | |
CN203468711U (en) | Multifunctional intrauterine adhesion control and treatment unit | |
CN101541256A (en) | Apparatus for collecting the amniotic fluid from the uterus | |
CN110559061A (en) | anti-adhesion tension-free uterine cavity conformable barrier and using method thereof | |
CN206508369U (en) | One uterine cryptomere support tube | |
Peng et al. | Exploration of the successful treatment algorithms used in 23 cases of early live cesarean scar pregnancy | |
CN203139357U (en) | Gynecological triple-bag multi-cavity tube | |
CN202859206U (en) | Carrier barrier system applied to prevention and treatment of intrauterine adhesion | |
CN203724193U (en) | Amniotic membrane pushing-in device for cerclage | |
CN203971144U (en) | Salpingography recanalization conduit | |
CN203329172U (en) | Device for preventing and treating intrauterine adhesion and cervical adhesion | |
CN206434397U (en) | A kind of uterus and uterine neck hemostasis sacculus | |
CN201692487U (en) | Double-sac cervix expanding duct | |
Quinlan | Researches into sterility of cows in South Africa | |
CN208081646U (en) | Three chamber uterine neck balloon dilatation catheters | |
CN208974055U (en) | Disposable improvement induction of labor with water bag device | |
CN209575501U (en) | The anti-multi-functional dressing of HPV beta glucan | |
CN103055408A (en) | Gynaecology three-balloon multi-cavity catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161005 Termination date: 20190414 |
|
CF01 | Termination of patent right due to non-payment of annual fee |